https://www.selleckchem.com/products/Eloxatin.html
RNA-Seq and immunoblotting analyses showed that the MEOX1 knockdown decreases expression of tyrosine kinase 2 (TYK2), signal transducer and activator of transcription 5B (STAT5, and STAT6 in P53- and PTEN-deficient TNBC cells. These results reveal the effects of combined P53/PTEN deficiency on MEOX1 expression and TNBC cell proliferation, suggesting that MEOX1 may serve as a potential therapeutic target for managing P53- and PTEN-deficient TNBC.The accumulation of amyloid Tau aggregates is implicated in Alzheimer's disease (AD) and o
Me gusta
Comentario
Compartir
